September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical
Words: 5468 - Pages: 22
CHAPTER 3: METHODOLOGY 3.1 Study Design This research is an experimental study which was conducted to investigate the effectiveness of treatment of Cassia alata as antioxidant effects in cardiovascular system of hyperglycemic rats. The antioxidant activity was tested from the leaf of Cassia alata using its aqueous extract. For this study, 30 Wistar rats weighing between 180 to 200g were used. They were housed in standard cages in a room with a 12 hour light/dark cycle and 50 to 60% relative humidity
Words: 2789 - Pages: 12
September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division
Words: 5468 - Pages: 22
As drug industry’s influence over research grows, so does the potential for bias The inside track on Washington politics. Be the first to know about new stories from PowerPost. Sign up to follow, and we’ll e-mail you free updates as they’re published. You’ll receive free e-mail news updates each time a new story is published. You’re all set! Sign up Steven Nissen, a heart specialist at The Cleveland Clinic, has linked pharmaceutical drugs such as Vioxx and Avandia with high cardiovascular
Words: 4274 - Pages: 18
Tohoku Aftermath on the WW Automotive Industry Market Researcher IHS iSuppli has come out with loss estimates from the earthquake and tsunami, correlating them to GDP. The Japanese GDP is estimated at $5.5 Trillion. It is the third largest, and around 8% of the WW economy. IHS iSuppli estimates suggest that if loss is around $250 Billion, the rebuild expense will be around $190 Billion. On the other hand, the World Bank estimates that the Japanese earthquake and resulting tsunami could cost the
Words: 2735 - Pages: 11
1) Pharmaceutical Industry in India: India is the third largest pharmaceutical market in the world in terms of volume. The market is believed to grow at a compound annual growth rage (CAGR) of 14-17 percent in between 2012-16. There has also been a considerable growth in the levels of pharmaceutical exports from India. The industry started picking momentum in the early 1960s, with government actively encouraging the sector with the Patents Act. However, the liberalization of 1991 enabled the industry
Words: 3952 - Pages: 16
GlaxoSmithKline company profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures
Words: 18642 - Pages: 75
IIM BANGALORE Final Report for Contemporary Concerns Study Project Repositioning Strategy for Indian Pharmaceutical Companies in Global Context Submitted to PROFESSOR MURALI PATIBANDLA (FACULTY,CORPORATE STRATEGY AND POLICY) Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry
Words: 7934 - Pages: 32
OF COMPETITIVE ADVANTAGE: KINETIC AND POSITIONAL By: Ma, Hao; Business Horizons, Jan/Feb2000, Vol. 43 Issue 1, p53, 12p, 1 diagram Competitive advantage is considered the basis for superior company performance. To perform at such a level consistently, a firm often has to nurture an evolving system of competitive advantages to carry it through competition and over time. What are the various possible types of such advantages? How can a firm systematically analyze the multiple advantages it could
Words: 8624 - Pages: 35
Strategy Template.dot Strategy INDIA INDIA June 28, 2010 BSE-30:17,575 The 100 Billion Dollar Club. We analyze Indian companies and their attributes such as (1) IPR (brand and technology), (2) financial and industrial assets and (3) natural resources that can propel them to US$100 bn market capitalization over a period of time. We also look at global experience to draw conclusions for India; every decade throws up new and interesting names. Finally, we assess operating factors that are
Words: 28995 - Pages: 116
